Cargando…

Interleukin 5 Contributes to Human Atherosclerosis Development But not to Thrombotic Complications

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Ait-Oufella, Hafid, Taleb, Soraya, Tedgui, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938843/ https://www.ncbi.nlm.nih.gov/pubmed/31909767 http://dx.doi.org/10.1016/j.jacbts.2019.11.005

Ejemplares similares

Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
por: Ait-Oufella, Hafid, et al.
Publicado: (2021)

Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling
por: Santos-Zas, Icia, et al.
Publicado: (2019)

The Pathogenic Transforming Growth Factor-β Overdrive Hypothesis in Aortic Aneurysms and Dissections: A Mirage?
por: Mallat, Ziad, et al.
Publicado: (2017)

B cell depletion reduces the development of atherosclerosis in mice
por: Ait-Oufella, Hafid, et al.
Publicado: (2010)

Myocardial infarction as a thrombotic complication of myeloproliferative disorders
por: Petrou, Emmanouil, et al.
Publicado: (2016)

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
por: Taleb, Soraya, et al.
Publicado: (2009)

Recruiting the microcirculation in septic shock
por: Legrand, Matthieu, et al.
Publicado: (2019)

Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy
por: Zhang, Yujiao, et al.
Publicado: (2023)

Atherosclerosis at your fingertips?
por: Swenne, C.A.
Publicado: (2015)

Targeting Phosphorylcholine in Established Atherosclerosis?
por: Tsiantoulas, Dimitrios
Publicado: (2020)

Fluid resuscitation should respect the endothelial glycocalyx layer
por: Guidet, Bertrand, et al.
Publicado: (2014)

The contribution of human conflict to the development of antimicrobial resistance
por: Pallett, Scott J. C., et al.
Publicado: (2023)

Reversible skin microvascular hyporeactivity in patients with immune-mediated thrombocytopenic thrombotic purpura
por: Joffre, Jérémie, et al.
Publicado: (2023)

Lessons from vaccine-induced immune thrombotic thrombocytopenia
por: Kelton, John Greenhow, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease, a Marker of Subclinical Atherosclerosis Applicable Only to Metabolic Syndrome?: Time to Organize the Connection between Metabolism and Atherosclerosis
por: Lee, Seung-Pyo
Publicado: (2012)

Subclinical atherosclerosis: A hidden threat for patients with ankylosing spondylitis
por: Hamdi, Wafa, et al.
Publicado: (2019)

Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?
por: Katsiki, Niki, et al.
Publicado: (2017)

Atherosclerosis should be a rare disease in the lives of children born today
por: Peters, R. J. G.
Publicado: (2017)

AIMing 2 treat atherosclerosis
por: Soehnlein, Oliver, et al.
Publicado: (2022)

A role for lipophagy in atherosclerosis
por: Laval, Thomas, et al.
Publicado: (2023)

Relationship between Urinary Albumin Excretion and Carotid Atherosclerosis in General Korean Population
por: Kim, Kye Hun
Publicado: (2010)

Neutrophil-to-Lymphocyte Ratio for Risk Assessment in Coronary Artery Disease and Carotid Artery Atherosclerosis
por: Park, Jun-Bean
Publicado: (2016)

Epicardial adipose tissue: Just a predictor or a local player for coronary atherosclerosis?
por: Izgi, Cemil
Publicado: (2015)

Speckle Tracking of Common Carotid Artery: A New Method for the Evaluation of Mechanical Vascular Function of Atherosclerosis
por: Choi, Jin-Oh
Publicado: (2016)

SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
por: Reuben, Rine Christopher, et al.
Publicado: (2021)

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Getting Closer and Closer
por: Toldo, Stefano, et al.
Publicado: (2017)

Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells
por: Ponnuswamy, Padmapriya, et al.
Publicado: (2017)

Feeding Sugar to Tumors: With a Supplement of miR?
por: Blanc‐Brude, Olivier P., et al.
Publicado: (2012)

TILRR Steers Interleukin-1 Signaling: Co-Receptor Provides Context and a Therapeutic Target
por: Mac Gabhann, Feilim
Publicado: (2017)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Correction to: Recruiting the microcirculation in septic shock
por: Legrand, Matthieu, et al.
Publicado: (2019)

β-blockers in hemodialysis: simple questions, complicated answers
por: Hundemer, Gregory L, et al.
Publicado: (2020)

The role of interleukin (IL)-23 in regulating pain in arthritis
por: Lee, Kevin M.-C., et al.
Publicado: (2022)

Reassurance on bleeding and thrombotic events following second dose BNT162b2 and ChAdOx1 COVID-19 vaccines
por: Pavord, Sue, et al.
Publicado: (2023)

Editorial Comment: Urologic surgery laparoscopic access: vascular complications
por: Sapre, Nikhil, et al.
Publicado: (2017)

Editorial Comment: Urologic surgery laparoscopic access: vascular complications
por: Correa, Jose Jaime
Publicado: (2017)

A Novel Embolization Technique to Stem Hemorrhage Complications and Cancer
por: Das, Undurti N
Publicado: (2020)

Contribution of Remnant Cholesterol to Coronary Atherosclerosis
por: Ohmura, Hirotoshi
Publicado: (2022)

Upper-extremity dysfunction following transradial percutaneous procedures: an overlooked and disregarded complication?
por: Hassell, M.E.C.J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qe1d6498not9no34uqc17gach5